Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis

被引:18
|
作者
Sidana, Surbhi [1 ]
Tandon, Nidhi [1 ]
Brady, Peter A. [2 ,3 ]
Grogan, Martha [2 ]
Gertz, Morie A. [1 ]
Dispenzieri, Angela [1 ]
Lin, Grace [2 ]
Dingli, David [1 ]
Buadi, Francis K. [1 ]
Lacy, Martha Q. [1 ]
Kapoor, Prashant [1 ]
Gonsalves, Wilson, I [1 ]
Muchtar, Eli [1 ]
Warsame, Rahma [1 ]
Kumar, Shaji K. [1 ]
Kourelis, Taxiarchis, V [1 ]
机构
[1] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA
[3] Iowa Heart Ctr, Iowa City, IA USA
关键词
STEM-CELL TRANSPLANTATION; CARDIAC AMYLOIDOSIS; HYPERTROPHIC CARDIOMYOPATHY; ATRIAL-FIBRILLATION; AL AMYLOIDOSIS; CONDUCTION SYSTEM; RISK; MANAGEMENT; DIAGNOSIS; OUTCOMES;
D O I
10.1016/j.mayocp.2018.08.039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate the prognostic impact of Holter findings in patients with light chain amyloidosis. Patients and Methods: We evaluated 239 patients in whom light chain amyloidosis was diagnosed from January 1, 2010, through December 31, 2015, who underwent 24-hour Holter monitoring. Results: Holter testing was done before stem cell transplant evaluation in 183 of the 239 patients (76.6%) and at diagnosis in 50 (20.9%). Holter findings were nonsustained ventricular tachycardia (NSVT) in 60 patients (25.1%), ventricular couplets in 103 (43.1)%, accelerated idioventricular rhythm in 32 (13.4%), and atrial fibrillation (AF) in 18 (7.5%). Overall survival (OS) at 3 and 6 months after Holter monitoring in patients with AF vs without AF was 78% (95% CI, 54%-91%) vs 96% (95% CI, 92%-98%) (P=.002) and 61% (95% CI, 38%-80%) vs 92% (95% CI, 87%-95%), (P<.001), respectively. In patients with and without NSVT, 3- and 6-month OS after Holter testing as 90% (95% CI, 80%-94%) vs 96% (95% CI, 91%-98%) (P=.12) and 77% (95% CI, 64%-85%) vs 94% (95% CI, 89%-97%) (P<.001), respectively. For patients with and without ventricular couplets, 3- and 6-month OS was 94% (95% CI, 88%-97%) vs 94% (95% CI, 89%-97%) (P=.98) and 84% (95% CI, 75%-89%) vs 94% (95% CI, 89%-97%) (P=.01), respectively. Atrial fibrillation (hazard ratio, 2.5; 95% CI, 1.2-5.0; P=.02) and NSVT (hazard ratio, 2.0; 95% CI, 1.1-3.5; P=.02) were independent predictors for OS after accounting for age and Mayo stage. For patients undergoing routine testing before stem cell transplant, AF (P=.002) and NSVT (P=.02) were associated with inferior OS at 6 months but did not retain statistical significance after adjusting for Mayo stage (P=.10 and P=.54, respectively). Conclusion: Atrial fibrillation and NSVT on 24-hour Holter monitoring are associated with inferior short-term OS outcomes but do not impact peritransplant mortality. (C) 2018 Mayo Foundation for Medical Education and Research
引用
收藏
页码:455 / 464
页数:10
相关论文
共 50 条
  • [21] Urinary Findings in Renal Light Chain-Derived Amyloidosis and Light Chain Deposition Disease
    Melmed, Gavin M.
    Fenves, Andrew Z.
    Stone, Marvin J.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (03): : 234 - 238
  • [22] BONE MARROW AND LABORATORY FINDINGS IN LIGHT CHAIN (AL) AMYLOIDOSIS
    Lee, Taegeun
    Park, Chan-Jeoung
    Lee, Min Young
    Ahn, Ari
    You, Eunkyoung
    Cho, Young-Uk
    Jang, Seongsoo
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 : 84 - 84
  • [23] A novel prognostic staging system for light chain amyloidosis (AL)
    Kumar, S.
    Dispenzieri, A.
    Lacy, M.
    Hayman, S.
    Buadi, F.
    Zeldenrust, S.
    Leung, N.
    Ramirez-Alvarado, M.
    Kyle, R. A.
    Rajkumar, S. V.
    Gertz, M.
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 182 - 182
  • [24] The prognostic significance of central hemodynamics in patients with cardiac amyloidosis
    Russo, Christopher
    Green, Philip
    Maurer, Mathew
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2013, 20 (04): : 199 - 203
  • [25] Prognostic significance of semiautomatic quantification of left ventricular long axis shortening in systemic light-chain amyloidosis
    Riffel, Johannes H.
    Mereles, Derliz
    Emami, Mostafa
    Korosoglou, Grigorios
    Kristen, Arnt V.
    Aurich, Matthias
    Voss, Andreas
    Schonland, Stefan O.
    Hegenbart, Ute
    Hardt, Stefan E.
    Katus, Hugo A.
    Buss, Sebastian J.
    [J]. AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2015, 22 (01): : 45 - 53
  • [26] Multiparameter Cardiac Magnetic Resonance to Monitor Therapeutic Effect After Chemotherapy in Light Chain Amyloidosis Patients
    Li, Xiao
    Huang, Sisi
    Miao, Huilei
    Shen, Kaini
    Lin, Lu
    Wang, Jian
    Cao, Jian
    Liu, Yajing
    Cao, Likun
    Li, Jian
    Jin, Zhengyu
    Wang, Yining
    [J]. JACC-CARDIOVASCULAR IMAGING, 2021, 14 (07) : 1485 - 1487
  • [27] Prognostic Significance of Circulating Plasma Cells Detected By Next Generation Flow Cytometry in Light (AL) Chain Amyloidosis
    Kastritis, Efstathios
    Kostopoulos, Ioannis, V
    Theodorakakou, Foteini
    Roussakis, Pantelis
    Panteli, Chrysanthi
    Orologas-Stavrou, Nikolaos
    Spiliopoulou, Vasiliki
    Migkou, Magdalini
    Papanikolaou, Asimina
    Gakiopoulou, Harikleia
    Fotiou, Despina
    Terpos, Evangelos
    Tsitsilonis, Ourania E.
    Dimopoulos, Meletios A.
    [J]. BLOOD, 2022, 140 : 1150 - 1151
  • [28] Prognostic Significance of Baseline High Risk Features during Follow-up in Immunoglobulin Light Chain Amyloidosis
    Tandon, Nidhi
    Sidana, Surbhi
    Dispenzieri, Angela
    Gertz, Morie A.
    Buadi, Francis K.
    Lacy, Martha Q.
    Dingli, David
    Fonder, Amie
    Hayman, Suzanne R.
    Hobbs, Miriam
    Gonsalves, Wilson I.
    Hwa, Yi L.
    Kapoor, Prashant
    Kyle, Robert A.
    Leung, Nelson
    Go, Ronald S.
    Lust, John A.
    Russell, Stephen J.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    [J]. BLOOD, 2017, 130
  • [29] IMPACT OF IMMUNOPARESIS IN PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS
    Rodriguez-Lobato, L. G.
    Fernandez de Larrea, C.
    Cibeira, M. T.
    Tovar, N.
    Arostegui, J. I.
    Rosinol, L.
    Elena, M.
    Yague, J.
    Blade, J.
    [J]. HAEMATOLOGICA, 2017, 102 : 516 - 516
  • [30] Prognostic value of plasma big endothelin-1 in patients with light chain cardiac amyloidosis
    Chen, Zhongli
    Shi, Anteng
    Wang, Zhiyan
    Chen, Yanjia
    Lin, Yahui
    Su, Mingming
    Dong, Hongbin
    Laptseva, Natallia
    Hu, Yuxiao
    Flammer, Andreas J.
    Duru, Firat
    Jin, Wei
    Chen, Liang
    [J]. HEART, 2024, 110 (18) : 1124 - 1132